FTSE 100 rose 0.06% at 7,023.92 points, while the FTSE 250 inched up 0.26% to 22,582 points
UK stocks made modest gains in early trading on Monday, edging higher as investors continued to bet on a global economic recovery with vaccine rollouts gathering pace.
London’s FTSE 100 rose 0.06% at 7,023.92 points, consolidating its position above 7,000 as investors balanced reopening optimism with a need to take stock following recent gains, while the FTSE 250 inched up 0.26% to 22,582 points early on.
US futures were a little lower after the S&P 500 and Dow Jones finished at record highs on Friday, with both indices advancing more than 1% last week.
In company news, manufacturing company turnaround specialist Melrose Industries was marked up 1.3% to 181.1p after agreeing to sell its Nortek Air Management business to Chicago-based Madison Industries for £2.62 billion.
Chemicals company Johnson Matthey rose 0.5% to £32.03 on news it has entered into a partnership with Finnish Minerals to establish a second battery materials plant in Finland and secured raw materials supply from Nornickle and SQM.
According to the company, these developments represent ‘important milestones on our journey towards developing a sustainable battery materials ecosystem and further demonstrate the progress we are making on the commercialisation of our business’.
Building insulation group Kingspan jumped 2.8% to £66.22 after it reported a 24% increase in first quarter sales, led by strength in mainland Europe, and said its outlook for the second quarter was positive.
Gas company Energean fell 3.3% to 829p after reporting wider annual losses as revenue dropped on lower energy prices.
Specialist wealth manager Mattioli Woods advanced 2.7% to 750p on announcing the acquisition of Caledonia Asset Management for up to £1.6 million.
Support services group Christie softened 2.7% to 108p after posting pandemic-impacted full year results showing a 46% drop in sales to £42.2 million and a lurch into loss.
Data solutions provider D4t4 Solutions gained 6.4% to 340p after the company lifted its outlook on profit after reporting strong performance in the second half of the year.
Billing and customer relationship management software provider Cerillion advanced 2% to 525p on news it expects to report a 25% increase in revenue for the first half to March 2021, having enjoyed its ‘strongest ever’ six month trading period.
The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.
Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.
There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.
Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.